In recent months, President Trump has turned his attention to Australia, voicing discontent with three cornerstone policies: the Pharmaceutical Benefits Scheme (PBS), biosecurity laws, and the News Media Bargaining Code. These policies, deeply embedded in Australia’s national framework, have drawn Trump’s ire as he pursues an “America First” trade agenda aimed at addressing perceived imbalances in global commerce. Why does Trump dislike these Australian laws? How do they impact U.S. interests? What are the broader implications for Australia as it navigates this trans-Pacific tension? Let’s take a look.

The Pharmaceutical Benefits Scheme: A Thorn in Big Pharma’s Side